Chardan Capital Increases Lexeo Therapeutics (NASDAQ:LXEO) Price Target to $25.00
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price objective increased by equities researchers at Chardan Capital from $23.00 to $25.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Chardan Capital’s target price indicates a potential upside of 227.23% from […]
More Stories
Sheriff Scheffler’s Seismic Resurgence: First 2025 Win Secured, PGA Championship Looming
By M. James Ward It took some time but the first win in 2025 for world-ranked number one Scottie Scheffler...
Cox Automotive Says Tariffs Impacted Wholesale Used Car Prices in April
By Naveen Athrappully Wholesale used vehicle prices in the United States rose in April on both a monthly and annual...
Trump Says Upcoming US–China Trade Talks Could Result in Tariff Reductions
By Joseph Lord President Donald Trump on May 8 indicated that upcoming talks between the United States and China “could”...
Robert Francis Prevost Elected as First American Pope
By T.J. Muscaro A new pope has been elected and he is American. The College of Cardinals have chosen Cardinal...
What We Know About the India–Pakistan Conflict
By Chris Summers Twelve Indian drones were shot down overnight after being intercepted by air defense systems, Pakistani army spokesman...
10 Fun Things To Do Online When Bored
It’s a lot easier to find ourselves in a state of boredom than it should be. After all, you’re very...